Search alternatives:
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
2141
-
2142
-
2143
-
2144
-
2145
Antimicrobial Activity of Glycyrrhizinic Acid Is pH-Dependent
Published 2024“…In general, the antimicrobial activity of GA increases as a function of decreasing pH (and thus increasing protonation of GA). …”
-
2146
Table 1_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls
Published 2025“…</p>Results<p>The injection of [D1G, ΔQ14] LvIC led to a decrease in locomotor activity in mice. This treatment also resulted in reduced expression of neuronal calcium sensor 1 (NCS-1) and neuroligin 3 (NLGN-3) in the prefrontal cortex (PFC), hippocampus (Hip), and caudate putamen (CPu). …”
-
2147
Table 2_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls
Published 2025“…</p>Results<p>The injection of [D1G, ΔQ14] LvIC led to a decrease in locomotor activity in mice. This treatment also resulted in reduced expression of neuronal calcium sensor 1 (NCS-1) and neuroligin 3 (NLGN-3) in the prefrontal cortex (PFC), hippocampus (Hip), and caudate putamen (CPu). …”
-
2148
Fluorescence Imaging of Neuroblastocyte Differentiation and Parkinson’s Brain Tissue Lesions Examined by a Norepinephrine-Activated Molecular Probe
Published 2025“…Compared to the previously developed probe <i><b>SXU-NEQ</b></i>, the self-fluorescence intensity of probe <i><b>DQF</b></i> decreased significantly (I<i><sub><b>DQF</b></sub></i>/I<i><sub><b>SXU‑NEQ</b></sub></i> = 35%). …”
-
2149
-
2150
Meta-analysis showing the overall effect of different statin types versus placebo for
Published 2025Subjects: -
2151
-
2152
-
2153
-
2154
-
2155
Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials.
Published 2025Subjects: -
2156
Analysis of randomized controlled trials stratified based on treatment duration.
Published 2025Subjects: -
2157
-
2158
-
2159
-
2160